Taiwan FDA registration 3c453f94e6f37838d66341fb7e16b6ea
Bundis Human Cystin C Set
TW: 邦迪斯人類胱蛋白C套組
Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Jan 25, 2013 – Jan 25, 2023ExpiredRegistration details
- Analysis ID
- 3c453f94e6f37838d66341fb7e16b6ea
- Customs Code
- DHA00602432701
Company information
- Manufacturer
- THE BINDING SITE GROUP LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- Cypin C in human serum, heparin lithium or EDTA plasma is quantified by turbidimetry and is used with a SPAPLUS analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1225 肌氨酸酐試驗系統(Creatininetestsystem)
- Import Information
- import
Dates and status
- Registration Date
- Jan 25, 2013
- Expiry Date
- Jan 25, 2023
About this record
Access comprehensive regulatory information for Bundis Human Cystin C Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3c453f94e6f37838d66341fb7e16b6ea and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices